{
  "authors": [
    {
      "author": "Maurizio Menichetti"
    },
    {
      "author": "Sebastiano Rosso"
    },
    {
      "author": "Elisa Menegatti"
    },
    {
      "author": "Maria Pazzaglia"
    }
  ],
  "doi": "10.1186/s13256-015-0758-6",
  "publication_date": "2015-11-27",
  "id": "EN114997",
  "url": "https://pubmed.ncbi.nlm.nih.gov/26607201",
  "source": "Journal of medical case reports",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "The present report describes the case of an 80-year-old white man with an intermediate to low early mortality risk of pulmonary embolism. He was successfully treated with rivaroxaban (administered orally as monotherapy), demonstrating rapid benefit without any adverse events."
}